Trials / Completed
CompletedNCT01863368
Clinical Evaluation of Systane® ULTRA Compared to OPTIVE® in Ocular Surface Staining
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 105 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare Systane® ULTRA lubricant eye drops to OPTIVE® lubricating eye drops for ocular surface staining within dry eye subjects and to evaluate the safety of Systane® ULTRA after 3 months of use.
Detailed description
Following a 2-week washout phase with saline eye drops, subjects were randomized to receive either Systane® ULTRA or OPTIVE® for the remainder of the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Preservative-free saline solution eyedrops | 1 drop in each eye, 4 times a day, for up to two weeks as washout prior to Phase I and Phase II. |
| OTHER | Systane® ULTRA lubricant eyedrops | |
| OTHER | OPTIVE® lubricating eyedrops |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2014-06-01
- Completion
- 2014-06-01
- First posted
- 2013-05-27
- Last updated
- 2015-08-04
- Results posted
- 2015-07-10
Source: ClinicalTrials.gov record NCT01863368. Inclusion in this directory is not an endorsement.